Opinion: Why CT must tackle the PBM problem.

Feb 17

Written By Jonathan Karush

Jonathan Karush

Face the Facts: Breaking down the cost of prescription drugs

US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain